Technical Analysis for ARMP - Armata Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
200 DMA Resistance | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
20 DMA Resistance | Bearish | -2.26% | |
Outside Day | Range Expansion | -2.26% | |
Wide Bands | Range Expansion | -2.26% | |
Gapped Up | Strength | -2.26% | |
Fell Below 20 DMA | Bearish | -2.26% | |
Wide Bands | Range Expansion | -2.26% | |
Fell Below 200 DMA | Bearish | -11.30% |
Alert | Time |
---|---|
Rose Above Previous Day's High | 2 days ago |
200 DMA Resistance | 2 days ago |
20 DMA Resistance | 2 days ago |
10 DMA Resistance | 2 days ago |
2x Volume Pace | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata's lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa, leveraging its proprietary phage-specific GMP manufacturing capabilities.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Pathogenic Bacteria Drug Resistance Gram Negative Bacteria Manufacturing Capabilities Pseudomonas Aeruginosa Bacteriophage Multiple Drug Resistance
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Antibiotics Bacteria Pseudomonas Staphylococcus Aureus Pathogenic Bacteria Drug Resistance Gram Negative Bacteria Manufacturing Capabilities Pseudomonas Aeruginosa Bacteriophage Multiple Drug Resistance
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.2565 |
52 Week Low | 1.0701 |
Average Volume | 15,657 |
200-Day Moving Average | 3.03 |
50-Day Moving Average | 3.19 |
20-Day Moving Average | 2.69 |
10-Day Moving Average | 2.85 |
Average True Range | 0.38 |
RSI (14) | 42.53 |
ADX | 25.37 |
+DI | 22.66 |
-DI | 14.19 |
Chandelier Exit (Long, 3 ATRs) | 2.31 |
Chandelier Exit (Short, 3 ATRs) | 3.40 |
Upper Bollinger Bands | 3.18 |
Lower Bollinger Band | 2.20 |
Percent B (%b) | 0.39 |
BandWidth | 36.45 |
MACD Line | -0.09 |
MACD Signal Line | -0.12 |
MACD Histogram | 0.0255 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.46 | ||||
Resistance 3 (R3) | 3.54 | 3.34 | 3.32 | ||
Resistance 2 (R2) | 3.34 | 3.12 | 3.30 | 3.27 | |
Resistance 1 (R1) | 2.96 | 2.98 | 2.86 | 2.88 | 3.22 |
Pivot Point | 2.76 | 2.76 | 2.71 | 2.72 | 2.76 |
Support 1 (S1) | 2.38 | 2.54 | 2.28 | 2.30 | 1.96 |
Support 2 (S2) | 2.18 | 2.40 | 2.14 | 1.91 | |
Support 3 (S3) | 1.80 | 2.18 | 1.87 | ||
Support 4 (S4) | 1.72 |